Syntensor

San Francisco, United States

Developer of drug and risk analysis platform designed to generate causal hypotheses for drug efficacy and systemic toxicity.

$4.2M raised

Oct 2024

Equity Crowdfunding

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Syntensor raised?

Syntensor has raised $4.2M in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in October 2024.

Who are Syntensor's investors?

Syntensor's investors include Lexi Ventures.

Where is Syntensor headquartered?

Syntensor is headquartered in San Francisco, United States.

What does Syntensor do?

Developer of drug and risk analysis platform designed to generate causal hypotheses for drug efficacy and systemic toxicity.

What stage is Syntensor at?

Syntensor is at the Equity Crowdfunding stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 1, 2024.

MLA

"Syntensor — Funding & Investors." VCBacked, October 1, 2024, https://www.vcbacked.co/company/syntensor. Accessed July 2, 2026.

APA

VCBacked. (2024). Syntensor — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/syntensor

Wikipedia (cite web)

{{cite web |title=Syntensor — Funding & Investors |url=https://www.vcbacked.co/company/syntensor |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 1, 2024.